HEMP — Hempalta Share Price
- CA$5.22m
- CA$6.62m
- CA$0.54m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.87 | ||
Price to Tang. Book | 2.34 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 10.65 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -114.89% | ||
Return on Equity | -235.22% | ||
Operating Margin | -957.48% |
Financial Summary
Year End 30th Sep | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CA$m | n/a | n/a | n/a | n/a | 0.54 | n/a | n/a | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Hempalta Corp. is a Canada-based agricultural technology company. The Company is focused on harnessing the potential of hemp. Its products are made from hemp grown sustainably in Southern Alberta and process the hemp using a HempTrain Advanced Processing Plant at its production facility in Calgary. It is focused on producing a diverse range of hemp-based commercial and consumer products. Its consumer products include Hemp-Fresco, HempyCat, Animal Bedding, Hemp Garden Mulch, Hemp Pak, and HempZorb. Its commercial products include Bast Fiber, Hurd, Micro Hurd, and Green Microfiber. The Company's consumer products are sold and distributed through various retail channels. The Company, through Hemp Carbon Standard Inc. (HCS), creates and distributes HCS Carbon Certificates across various categories, including regenerative practices, biochar, and biomass burial, certifying the capture and long-term storage of carbon dioxide through sustainable hemp farming practices.
Directors
- Last Annual
- September 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 30th, 2021
- Public Since
- January 21st, 2022
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
TSX Venture Exchange
- Shares in Issue
- 94,944,176

- Address
- 1560 Hastings Crescent SE, CALGARY, T2G 4E1
- Web
- https://www.hempalta.com
- Phone
- +1 5874345554
- Auditors
- GEIB & Company
Upcoming Events for HEMP
Similar to HEMP
BioNeutra Global
TSX Venture Exchange
Canyon Creek Food
TSX Venture Exchange
CubicFarm Systems
TSX Venture Exchange
Deveron
TSX Venture Exchange
Fresh Factory BC
TSX Venture Exchange
FAQ
As of Today at 21:04 UTC, shares in Hempalta are trading at CA$0.06. This share price information is delayed by 15 minutes.
Shares in Hempalta last closed at CA$0.06 and the price had moved by -71.79% over the past 365 days. In terms of relative price strength the Hempalta share price has underperformed the Toronto Stock Exchange 300 Composite Index by -74.58% over the past year.
There is no consensus recommendation for this security.
Find out moreHempalta does not currently pay a dividend.
Hempalta does not currently pay a dividend.
Hempalta does not currently pay a dividend.
To buy shares in Hempalta you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.06, shares in Hempalta had a market capitalisation of CA$5.22m.
Here are the trading details for Hempalta:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: HEMP
Based on an overall assessment of its quality, value and momentum Hempalta is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hempalta. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +40.52%.
As of the last closing price of CA$0.06, shares in Hempalta were trading -49.24% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Hempalta PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Hempalta's directors